Advanced Ovarian Cancer and Doxorubicin
Links shared publicly online about this topic
Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability - ONA
oncologynurseadvisor.com — “The combination of oxaliplatin and doxorubicin showed promising efficacy in either platinum-sensitive or platinum-resistant recurrent ovarian cancer, as reported by Ilya Pokateav, MD, from the Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, and colleagues at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 5, 2011 at 5:23 pm By:
Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability http://goo.gl/fb/ldXlW
Treatment for Advanced Ovarian Cancer Effective
disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancer” View full resource at disabled-world.com
Most Recently Shared on June 6, 2010 at 11:31 pm By:
Treatment for Advanced Ovarian Cancer Effective http://ff.im/-lA8Uw
For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard o” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 3:37 pm By:
For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin De.. http://dld.bz/AcP7
Novartis Phase III Trial Examining EPO906 (patupilone) For Patients With Advanced Ovarian Cancer Failed To Meet Primary Endpoint
medicalnewstoday.com — “Novartis announced that patupilone (EPO906) did not show a significant overall survival advantage in a phase III trial of patients with advanced ovarian cancer, refractory or resistant to platinum” View full resource at medicalnewstoday.com
Most Recently Shared on June 1, 2010 at 3:11 pm By:
Novartis Phase III Trial Examining EPO906 (patupilone) For Patients With Advanced Ovarian Cancer Failed To Meet Primar... http://mnt.to/3DkL
Ovarian Cancer
springer.com — “Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of ...” View full resource at springer.com
Most Recently Shared on March 16, 2012 at 6:27 pm By:
Ovarian Cancer: Second Editionseries:Cancer Treatment and ResearchOvarian carcinoma continues to be responsible ... http://t.co/GanmC9SK
Novel Agent Demonstrates Activity in Heavily Pretreated Ovarian Cancer That Progressed on Pegylated Doxorubicin
onclive.com — “A novel topoisomerase-I inhibitor designated NKTR-102 demonstrated clinically significant activity as a single agent in patients with heavily pretreated ovarian cancer who failed prior PLD.” View full resource at onclive.com
Most Recently Shared on August 1, 2011 at 2:29 pm By:
Novel Agent Demonstrates Activity in Heavily Pretreated Ovarian Cancer That Progressed on Pegylated Doxorubicin http://t.co/jz7fFD3
Ovarian cancer advances when genes are silenced
eurekalert.org — “Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.” View full resource at eurekalert.org
Most Recently Shared on December 14, 2010 at 4:41 pm By:
Ovarian cancer advances when genes are silenced ---> http://dld.bz/ANpD
Ovarian cancer advances when genes are silenced
labspaces.net — “There are many mechanisms that alter the activity of genes -- direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.” View full resource at labspaces.net
Most Recently Shared on December 14, 2010 at 4:48 pm By:
Ovarian cancer advances when genes are silenced - http://is.gd/iJVou
Key advances in ovarian cancer (ASCO 2010 ) Video
vodpod.com — “Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses research demonstrating the effectiveness of combining bevacizumab with chemotherapy as first line treatment of ovarian cancer. A second key presentation was research indicating that PARP inhibitors are effective at treating not just ovarian cancer caused by BRCA mutation but also high grade serous cancer. If this result is confirmed in further studies, it wo” View full resource at vodpod.com
Most Recently Shared on July 22, 2010 at 9:59 pm By:
Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun
Ovarian cancer advances when genes are silenced
sciencedaily.com — “Researchers have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.” View full resource at sciencedaily.com
Most Recently Shared on December 14, 2010 at 3:38 am By:
Ovarian cancer advances when genes are silenced: Researchers have found evidence of epigenetics at work on a gen... http://bit.ly/hM8eZ9
7 Clues to Ovarian Cancer
webmd.com — “Seven symptoms often reported to doctors are associated with ovarian cancer, according to a new study from the U.K., dispelling the idea that the deadly cancer is a ''silent killer'' with few clues until the advanced stages.” View full resource at webmd.com
Most Recently Shared on August 25, 2009 at 11:47 pm By:
7 Clues to Ovarian Cancer: Seven symptoms often reported to doctors are associated with ovarian cancer, accordin.. http://bit.ly/17OJmo
Ovarian Cancer Genes Found
webmd.com — “A newly identified group of genes may play a role in ovarian cancer risk, a study shows.” View full resource at webmd.com
Most Recently Shared on September 20, 2010 at 5:06 pm By:
Ovarian Cancer Genes Found: A newly identified group of genes may play a role in ovarian cancer risk, a study shows. http://bit.ly/d0fl6C
Ovarian Cancer Genes Found
webmd.com — “A newly identified group of genes may play a role in ovarian cancer risk, a study shows.” View full resource at webmd.com
Most Recently Shared on September 20, 2010 at 8:13 pm By:
Ovarian Cancer Genes Found
webmd.com — “A newly identified group of genes may play a role in ovarian cancer risk, a study shows.” View full resource at webmd.com
Most Recently Shared on September 20, 2010 at 8:15 pm By:
Could a newly discovered group of genes help predict your ovarian cancer risk? http://bit.ly/cZ9GHA (via @WebMD)
Stopping Ovarian Cancer
health.com — “Cutting-edge advances are transforming ovarian cancer from a death sentence into a disease women can beat. See how the detection and treatment breakthroughs that are already saving lives.” View full resource at health.com
Most Recently Shared on August 19, 2011 at 1:35 pm By:
Transforming #ovarian #cancer from a death sentence into a disease women can beat. Read on for treatment breakthroughs: http://t.co/OJlMHUW
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
Disabled World
Disabled World is managed by Lynn and Ian Langtree, a couple dedicated to assisting seniors and people with disabilities.
-
medical_tweets
Advertisement

